SEC Form 4 · accession 0001567619-18-003362
Medpace Holdings, Inc. · MEDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
August J. Troendle
Officer — President & CEO · Director · 10% Owner
Period of report
Sep 28, 2018
Accepted (ET)
Oct 1, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001668397
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 28, 2018 | J | 748,459 | $59.91 | D | 8,147,051 | I | By Medpace Investors, LLC |
| Common Stock | Sep 28, 2018 | J | 251,851 | $59.91 | A | 603,702 | D | |
| Common Stock | holding | — | — | — | 10,000 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents distributions of MEDP shares in-kind to the holders of Medpace Investors, LLC's ("MPI") Incentive Units.
- F2The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the shares held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F3Represents the receipt of the allocable portion of shares in the distribution by MPI as more fully described in Footnote 1.